Trends in treatment‐related deaths (TRDs) in childhood cancer and leukemia over time: A follow‐up of patients included in the childhood cancer registry of the Rhône‐Alpes region in France (ARCERRA)
- 25 February 2008
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 50 (6), 1213-1220
- https://doi.org/10.1002/pbc.21506
Abstract
Background We assessed the number and causes of treatment-related deaths (TRDs) in childhood cancer over time and correlated them with adherence to therapeutic guidelines. Procedure We compared two cohorts of children of the Childhood Cancer Registry of the Rhône-Alpes Region: Cohort I (1987–1992, 909 patients) and Cohort II (1996–1999, 648 patients). Results In all cancers together, 75 TRDs were reported in Cohort I and 24 in Cohort II (P = 0.001). Cumulative incidence at 5 years declined from 7.9% to 4.1%, and overall survival (OS) increased from 71.0% to 77.2%. TRDs declined by nearly 10-fold in patients with solid malignant tumors (P = 0.02) and central nervous system tumors (P = 0.001), but OS improved for patients with solid malignant tumors only (P = 0.01). No difference was observed in treatment- and transplantation-related deaths in patients with acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML), but OS was better in patients with AML (P = 0.02). Between the two cohorts, transplantation-related mortality did not decrease and was higher at 5 years in patients with ALL who received unrelated-matched donor transplants (41.3%) than in those receiving sibling-matched donor transplants (18.7%). OS improved in the respective transplant groups (37.0% and 64.2%). Severe graft-versus-host disease was also observed among patients with ALL (P = 0.036). The decrease in TRDs was correlated with compliance to therapeutic guidelines. Conclusion Although mortality declined, improved adherence to therapeutic guidelines and more restricted indications of allograft are needed to preclude further treatment- and transplantation-related deaths, particularly among those with leukemia. Pediatr Blood Cancer 2008;50:1213–1220.Keywords
Funding Information
- Ligue Française contre le Cancer
- Centre Hospitalo-Universitaire de Saint-Etienne
- ONCORA
- Conseil Regional de Rhône-Alpes
- Institut National de Veille Sanitaire
- Fondation de France
This publication has 27 references indexed in Scilit:
- Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2007
- Survival in France after childhood acute leukaemia and non-Hodgkin’s lymphoma (1990–2000)European Journal Of Cancer, 2006
- Les cancers de l'enfant de la région Rhône-Alpes : incidence et survie 1987–1999Archives de Pédiatrie, 2006
- Treatment‐related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001British Journal of Haematology, 2005
- Causes of death – other than progressive leukemia – in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experienceLeukemia, 2005
- Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98Journal of Clinical Oncology, 2004
- Long‐term cause‐specific mortality among five‐year survivors of childhood cancerPediatric Blood & Cancer, 2004
- Progressive reduction in treatment‐related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)British Journal of Haematology, 2001
- Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situationBone Marrow Transplantation, 2000
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958